Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine

BMC pharmacology & toxicology

Volumn 15, Issue , 2014, Pages 42-

  Singhal, Rohit ^a   Harrill, Alison H ^a   Menguy Vacheron, Francoise ^a   Jayyosi, Zaid ^a   Benzerdjeb, Hadj ^a   Watkins, Paul B ^b  

^a Research Triangle Park ^*

^b Hamner University of North Carolina Institute for Drug Safety Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COLESTYRAMINE; PLACEBO;

BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HUMAN; LIVER; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHOLESTYRAMINE RESIN; DOUBLE-BLIND METHOD; HEALTHY VOLUNTEERS; HUMANS; LIVER; PLACEBOS;

EID: 84924813068     PISSN: None     EISSN: 20506511     Source Type: Journal    
DOI: 10.1186/2050-6511-15-42     Document Type: Article

References (0)